TABLE 3.

Changes of average Hb (g/dL) levels at weeks 18 to 24 and weeks 46 to 52 from baseline (full analysis set)

Parameter	ESA‐Naïve Studya			ESA‐Converted Studyb
	Roxadustat 50 mg	Roxadustat 70 mg	All ESA‐Naïve	All ESA‐Converted
	N = 37	N = 37	N = 74	N = 163
Weeks 18‐24
n	33	32	65	148
Mean (SD)	2.29 (1.05)	2.24 (1.01)	2.26 (1.02)	−0.03 (0.90)
Median	2.40	2.25	2.30	0.00
Range	0.2‐4.2	0.4‐4.5	0.2‐4.5	−3.2 to 1.9
Weeks 46‐52
n	—	—	—	128
Mean (SD)	—	—	—	0.12 (0.83)
Median	—	—	—	0.10
Range	—	—	—	−2.6 to 2.0

Abbreviations: ESA, erythropoiesis‐stimulating agent; Hb, hemoglobin.

^aThe study duration was 24 weeks.

^bThe study duration was 52 weeks.